GSK plc
NYSEGSK reports Q2 results on July 29 having just delivered its strongest week since early 2026, and the options market is finally reflecting that shift in mood. The most striking change since the last preview is in options positioning — and it now runs in the opposite direction. The put/call ratio has dropped to 1.12, more than two standard deviations below its 20-day average of 1.31…
GSK short interest surged 64% over one week to 14.3M shares as of July 17, driven by rising bearish sentiment in pharma despite low 0.63% cost to borrow.
GSK reports Q2 results on July 29 having just delivered its strongest week since early 2026, and the options market is finally reflecting that shift in mood. The most striking change since the last preview is in…
GSK heads into Tuesday's Q2 results with one notable shift since the last preview: options positioning has eased from its most defensive levels, even as the stock remains a relative underperformer against the broader…
Snapshot as of 6 Aug 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GSK — free to start on ORTEX.
Sign up for free →Open GSK on ORTEX